company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7217000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7217000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,167000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,94000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,523000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-221000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6654000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6654000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,1000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-34035000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4750000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-29284000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-29284000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-534000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,49928000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,49394000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,49394000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,13456000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q3,2010-07-01,2010-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,46000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6244000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6244000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,76000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,169000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,798000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-548000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5749000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5743000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-15000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4500000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4485000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4485000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1185000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-72507000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,72639000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1053000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1053000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2311000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2010.0,Q4,2010-10-01,2010-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,23000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:12:14+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10133000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:12:14+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10133000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:12:14+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,74000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:12:14+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,119000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:12:14+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,648000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:12:14+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1068000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:12:14+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8224000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:12:14+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8224000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:12:14+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:12:14+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-10220000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:12:14+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,22244000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:12:14+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,12019000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:12:14+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,12019000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:12:14+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-488000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:12:14+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,41000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:12:14+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-447000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:12:14+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-447000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:12:14+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3348000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 16:12:14+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,11000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11250000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11250000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,73000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,87000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,668000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2250000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8172000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8172000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-492000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8544000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8500000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-536000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-536000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,10000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,75000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,61827000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,61912000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,61912000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,53204000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q2,2011-04-01,2011-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10438000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10438000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,89000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,154000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,558000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,381000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9256000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9256000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-96000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-54111000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4950000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-49257000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-49257000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-34000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,10000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-24000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-24000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-58537000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q3,2011-07-01,2011-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,7000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12385000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12385000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,91000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,127000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,430000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1253000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10484000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10484000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-139000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6831000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10080000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3110000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3110000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-34000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-18000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,438000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,61018000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-61308000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,96000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,96000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7278000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,13000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 16:12:14+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9141000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 16:12:14+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9141000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 16:12:14+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,100000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 16:12:14+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,98000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 16:12:14+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1569000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 16:12:14+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-609000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 16:12:14+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11121000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 16:12:14+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11121000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 16:12:14+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-475000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 16:12:14+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-26707000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 16:12:14+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,49950000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 16:12:14+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,22768000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 16:12:14+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,22768000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 16:12:14+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-35000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 16:12:14+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1767000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 16:12:14+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1732000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 16:12:14+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1732000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 16:12:14+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,13379000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q1,2012-01-01,2012-03-31,2012-05-09 16:12:14+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,9000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11527000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11527000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,-309000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-301000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-166000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2231000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10072000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10072000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-101000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6138000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5000000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1239000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1239000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-81000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,609000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,88000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-530000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,86000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,86000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11225000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q2,2012-04-01,2012-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,24000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15255000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15255000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,528000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,517000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3782000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1726000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12154000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12154000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-52000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-38206000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10500000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-27758000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-27758000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-82000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,41682000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,889000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,42489000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,42489000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2577000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q3,2012-07-01,2012-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,13000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11204000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11204000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,89000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,130000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1131000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3333000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13187000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13187000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-28000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8708000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,19600000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,10864000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,10864000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-84000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-247000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,87000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,252000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2315000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,14000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:58:50+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11738000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:58:50+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11738000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:58:50+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,98000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:58:50+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,249000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:58:50+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1478000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:58:50+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-301000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:58:50+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13170000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:58:50+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13170000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:58:50+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-143000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:58:50+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-119747000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:58:50+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,20700000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:58:50+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-99190000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:58:50+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-99190000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:58:50+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:58:50+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,86000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:58:50+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,133211000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:58:50+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,107000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:58:50+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,133232000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:58:50+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,133232000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:58:50+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,20872000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q1,2013-01-01,2013-03-31,2014-05-07 15:58:50+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,14000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19940000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19940000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,99000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,707000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1488000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4405000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13241000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13241000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-95000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-25200000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,16165000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9130000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9130000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,210000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,210000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-22161000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q2,2013-04-01,2013-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,13000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13919000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13919000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,99000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,721000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1067000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1218000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13250000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13250000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3565000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,25265000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,21693000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,21693000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-50000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-50000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,8393000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q3,2013-07-01,2013-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,9000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13350000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13350000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,103000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,683000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1456000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2867000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13975000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13975000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-163000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-19605000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,41361000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,21593000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,21593000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,209000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,209000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7827000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,10000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:34:52+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16088000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:34:52+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16088000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:34:52+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,111000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:34:52+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,600000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:34:52+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1015000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:34:52+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1004000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:34:52+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13358000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:34:52+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13358000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:34:52+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-218000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:34:52+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-41518000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:34:52+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,55921000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:34:52+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,14185000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:34:52+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,14185000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:34:52+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-91000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:34:52+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-77000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:34:52+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:34:52+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:34:52+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:34:52+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-163000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:34:52+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-163000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:34:52+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,664000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:34:52+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,12000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15657000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15657000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,121000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,528000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1458000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-258000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13808000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13808000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-28000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-13509000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,25048000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,11511000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,11511000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-92000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-5000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,96000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1445000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1444000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1444000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-853000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q2,2014-04-01,2014-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,8000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12178000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12178000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-71000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-13776000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,24653000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,10806000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,10806000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-54000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7768000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7714000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7714000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6342000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q3,2014-07-01,2014-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,5000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16180000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16180000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-630000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-10535000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,18003000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6838000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6838000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-76000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,82000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,440000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,42850000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,100000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,43396000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,43396000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,34054000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,10000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,2015-01-01,2015-03-31,2015-05-07 07:34:52+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19263000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,2015-01-01,2015-03-31,2015-05-07 07:34:52+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19263000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,2015-01-01,2015-03-31,2015-05-07 07:34:52+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,160000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,2015-01-01,2015-03-31,2015-05-07 07:34:52+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,385000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,2015-01-01,2015-03-31,2015-05-07 07:34:52+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1878000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,2015-01-01,2015-03-31,2015-05-07 07:34:52+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-481000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,2015-01-01,2015-03-31,2015-05-07 07:34:52+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17321000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,2015-01-01,2015-03-31,2015-05-07 07:34:52+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17321000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,2015-01-01,2015-03-31,2015-05-07 07:34:52+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-74000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,2015-01-01,2015-03-31,2015-05-07 07:34:52+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-209108000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,2015-01-01,2015-03-31,2015-05-07 07:34:52+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,60605000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,2015-01-01,2015-03-31,2015-05-07 07:34:52+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-148577000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,2015-01-01,2015-03-31,2015-05-07 07:34:52+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-148577000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,2015-01-01,2015-03-31,2015-05-07 07:34:52+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,2015-01-01,2015-03-31,2015-05-07 07:34:52+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,319000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,2015-01-01,2015-03-31,2015-05-07 07:34:52+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,138291000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,2015-01-01,2015-03-31,2015-05-07 07:34:52+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,527000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,2015-01-01,2015-03-31,2015-05-07 07:34:52+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,138957000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,2015-01-01,2015-03-31,2015-05-07 07:34:52+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,138957000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,2015-01-01,2015-03-31,2015-05-07 07:34:52+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-26941000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q1,2015-01-01,2015-03-31,2015-05-07 07:34:52+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,21000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28978000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28978000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,161000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,515000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2074000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,9314000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16914000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16914000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-247000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-34851000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,64446000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,29348000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,29348000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2541000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2541000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,14975000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q2,2015-04-01,2015-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,7000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,26259000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,26259000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,184000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,533000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1476000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,26978000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,55430000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,55430000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-290000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-227767000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,102078000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-125979000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-125979000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,54000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,158877000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,459000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,159282000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,159282000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,88733000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q3,2015-07-01,2015-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,11000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,16952000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,16952000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,189000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,569000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2160000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-35488000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15618000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15618000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-93000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-220799000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,167446000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-53446000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-53446000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,358000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,358000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-68706000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,11000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:12:56+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18054000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:12:56+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18054000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:12:56+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,192000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:12:56+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,383000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:12:56+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2731000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:12:56+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1436000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:12:56+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16184000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:12:56+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16184000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:12:56+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-394000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:12:56+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-172463000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:12:56+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,166115000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:12:56+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6742000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:12:56+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6742000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:12:56+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-54000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:12:56+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:12:56+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:12:56+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:12:56+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-54000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:12:56+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-54000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:12:56+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-22980000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q1,2016-01-01,2016-03-31,2016-05-03 16:12:56+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,14000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18493000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18493000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,240000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,413000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2290000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1393000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16943000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16943000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-861000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-158341000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,151036000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8166000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8166000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-56000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,126000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,71000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,141000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,141000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-24968000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q2,2016-04-01,2016-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,11000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15371000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15371000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-510000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-73228000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,95749000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,22011000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,22011000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-55000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-55000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-55000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6585000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q3,2016-07-01,2016-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,8000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17155000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17155000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-743000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-95083000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,149392000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,53566000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,53566000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-81000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,444000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,88000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,37000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,488000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,488000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,36899000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2016.0,Q4,2016-10-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,13000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:45:50+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20152000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:45:50+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20152000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:45:50+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,295000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:45:50+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,180000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:45:50+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2684000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:45:50+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,11193000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:45:50+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5800000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:45:50+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5800000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:45:50+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-214000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:45:50+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-121621000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:45:50+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,93719000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:45:50+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-28116000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:45:50+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-28116000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:45:50+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-93000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:45:50+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-175000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:45:50+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:45:50+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-266000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:45:50+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-266000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:45:50+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-34182000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:45:50+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,17000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22543000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22543000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,270000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,196000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2158000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3062000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16857000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16857000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-120000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-86984000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,96239000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9135000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9135000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-93000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,127000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,34000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,34000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7688000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q2,2017-04-01,2017-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,13000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19338000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19338000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,277000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,353000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2193000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-57000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16572000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16572000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-213000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-57079000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,90626000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,33334000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,33334000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-96000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,37000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-59000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-59000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,16703000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q3,2017-07-01,2017-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,9000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23203000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23203000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,284000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,350000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2444000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-124000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20249000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20249000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-79000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-79806000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,91507000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,11622000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,11622000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-69000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,98000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,29000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,29000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8598000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,13000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:03:06+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20588000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:03:06+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20588000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:03:06+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,289000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:03:06+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,191000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:03:06+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2550000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:03:06+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6540000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:03:06+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-24098000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:03:06+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-24098000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:03:06+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-178000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:03:06+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-62229000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:03:06+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,78685000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:03:06+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,16278000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:03:06+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,16278000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:03:06+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-58000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:03:06+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1304000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:03:06+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1246000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:03:06+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1246000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:03:06+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6574000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:03:06+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,13000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17199000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17199000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,282000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-31000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3276000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,460000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13212000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13212000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-174000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-62154000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,73104000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,10776000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,10776000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-37000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,102000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,570000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,635000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,635000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1801000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q2,2018-04-01,2018-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,8000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15884000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15884000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,287000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-326000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1611000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1312000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13000000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13000000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-116000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-48646000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,62960000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,14198000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,14198000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-37000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,9000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-28000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-28000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1170000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q3,2018-07-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,5000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16601000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16601000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,300000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-475000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1933000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3141000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11702000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11702000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-47000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-50031000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,75142000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,25064000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,25064000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-38000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,44000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,170000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,176000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,176000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,13538000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,11000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:03:06+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18959000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:03:06+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18959000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:03:06+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,300000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:03:06+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-699000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:03:06+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1635000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:03:06+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:03:06+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17727000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:03:06+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17727000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:03:06+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-70000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:03:06+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-65515000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:03:06+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,83105000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:03:06+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,17520000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:03:06+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,17520000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:03:06+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-131000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:03:06+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:03:06+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-131000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:03:06+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-131000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:03:06+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-338000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:03:06+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,9000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19426000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19426000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,296000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-703000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1620000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4137000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14076000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14076000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-21000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-45890000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,2000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,45000000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-909000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-909000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,79000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,291000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,370000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,370000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14615000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q2,2019-04-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,8000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19583000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19583000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,272000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-473000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1744000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1570000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16470000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16470000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-86000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-77322000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,99050000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,21642000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,21642000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3519000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3519000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3519000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,8691000.0
Achillion Pharmaceuticals Inc,ACHN,,0001070336,2019.0,Q3,2019-07-01,2019-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1000.0
